ACCUM-002 Trademark

Trademark Overview


On Monday, August 28, 2023, a trademark application was filed for ACCUM-002 with the United States Patent and Trademark Office. The USPTO has given the ACCUM-002 trademark a serial number of 98154157. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, May 22, 2025. This trademark is owned by Defence Therapeutics Inc.. The ACCUM-002 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Drug delivery agents consisting of intracellular enhancers in the nature of compounds that facilitate delivery of a wide range of pharmaceuticals; medicinal preparations for use in oncology; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; vaccines for human use

Antibody testing, namely, antibody profiling for scientific research purposes; research and development of vaccines and medicines; scientific research for medical purposes in the field of oncology
accum-002

General Information


Serial Number98154157
Word MarkACCUM-002
Filing DateMonday, August 28, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, May 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDrug delivery agents consisting of intracellular enhancers in the nature of compounds that facilitate delivery of a wide range of pharmaceuticals; medicinal preparations for use in oncology; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; vaccines for human use
Pseudo MarkACCUM ZERO ZERO TWO
Goods and ServicesAntibody testing, namely, antibody profiling for scientific research purposes; research and development of vaccines and medicines; scientific research for medical purposes in the field of oncology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 26, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 26, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDefence Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, B.C. V6C3L6
CA

Trademark Events


Event DateEvent Description
Thursday, August 31, 2023NEW APPLICATION ENTERED
Tuesday, September 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 25, 2024NON-FINAL ACTION WRITTEN
Tuesday, April 23, 2024ASSIGNED TO EXAMINER
Thursday, April 25, 2024NON-FINAL ACTION E-MAILED
Thursday, April 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 19, 2024SUSPENSION LETTER WRITTEN
Friday, August 16, 2024ASSIGNED TO EXAMINER
Monday, August 19, 2024LETTER OF SUSPENSION E-MAILED
Monday, August 19, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 17, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, March 18, 2025SUSPENSION INQUIRY WRITTEN
Tuesday, March 18, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, March 18, 2025INQUIRY TO SUSPENSION E-MAILED
Tuesday, May 6, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, May 20, 2025ASSIGNED TO LIE
Wednesday, May 21, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 21, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 22, 2025LETTER OF SUSPENSION E-MAILED
Thursday, May 22, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 22, 2025SUSPENSION LETTER WRITTEN